Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?

References

• Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25:6852-62. doi:10.1016/j.vaccine.2007.07.027.
   PubMed Web of Science ®Google Scholar
• Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523:217-20. doi:10.1038/nature14460. PMID:26053121
   PubMed Web of Science ®Google Scholar
• Barberis I, Myles P, Ault SK, Bragazzi NL, Martini M. History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines. J Prev Med Hyg. 2016;57:E115−20. PMID:27980374
   PubMedGoogle Scholar
• Alan H, Ian B, Nancy C, Ruben O D, Siddhivinayak H, Daniel J, Jacqueline K, John M, Fernando M, Takato O, et al. Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015. Vaccine. 2017;35:1104-9. doi:10.1016/j.vaccine.2017.01.018. PMID:28131392
   PubMed Web of Science ®Google Scholar
• Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16:942-51. doi:10.1016/S1473-3099(16)00129-8. PMID:27061888
   PubMed Web of Science ®Google Scholar
• Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, et al. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014–2015. J Infect Dis. 2016;214:1010-9. doi:10.1093/infdis/jiw181. PMID:27190176
   PubMed Web of Science ®Google Scholar
• Pebody RG, Warburton F, Ellis J, Andrews N, Thompson C, Wissmann von B, Green HK, Cottrell S, Johnston J, de Lusignan S, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill. 2015;20:21025. doi:10.2807/1560-7917.ES2015.20.5.21025. PMID:25677050
   PubMedGoogle Scholar
• Chong Y, Ikematsu H. Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants. Vaccine. 2017;35:255-63. doi:10.1016/j.vaccine.2016.11.084. PMID:27919631
   PubMed Web of Science ®Google Scholar
• ARCHETTI I, HORSFALL FL. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J Exp Med. 1950;92:441-62. doi:10.1084/jem.92.5.441.
   PubMed Web of Science ®Google Scholar
• Gerhard W, Webster RG. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med. 1978;148:383-92. doi:10.1084/jem.148.2.383. PMID:359746
   PubMed Web of Science ®Google Scholar
• Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe. 2013;13:314-23. doi:10.1016/j.chom.2013.02.008. PMID:23498956
   PubMed Web of Science ®Google Scholar
• Boni MF. Vaccination and antigenic drift in influenza. Vaccine. 2008;26:C8−C14. doi:10.1016/j.vaccine.2008.04.011.
   Web of Science ®Google Scholar
• Nelson MI, Holmes EC. The evolution of epidemic influenza. Nat Rev Genet. 2007;8:196-205. doi:10.1038/nrg2053.
   PubMed Web of Science ®Google Scholar
• Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 1981;289:373-8. doi:10.1038/289373a0. PMID:6162101
   PubMed Web of Science ®Google Scholar
• Knossow M, Daniels RS, Douglas AR, Skehel JJ, Wiley DC. Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin. Nature. 1984;311:678-80. doi:10.1038/311678a0.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME, Fouchier RAM. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305:371-6. doi:10.1126/science.1097211.
   PubMed Web of Science ®Google Scholar
• Hoelzer K, Murcia PR, Baillie GJ, Wood JLN, Metzger SM, Osterrieder N, Dubovi EJ, Holmes EC, Parrish CR. Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs. J Virol. 2010;84:5329-35. doi:10.1128/JVI.02469-09. PMID:20219907
   PubMed Web of Science ®Google Scholar
• Murcia PR, Baillie GJ, Stack JC, Jervis C, Elton D, Mumford JA, Daly J, Kellam P, Grenfell BT, Holmes EC, et al. Evolution of equine influenza virus in vaccinated horses. J Virol. 2013;87:4768-71. doi:10.1128/JVI.03379-12.
   PubMed Web of Science ®Google Scholar
• Swayne DE, Suarez DL, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M, McGrane J, Weaver J, Daniels P, Wong F, et al. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. J Virol. 2015;89:3746-62. doi:10.1128/JVI.00025-15. PMID:25609805
   PubMed Web of Science ®Google Scholar
• Connie Leung YH, Luk G, Sia S-F, Wu Y-O, Ho C-K, Chow K-C, Tang S-C, Guan Y, Malik Peiris JS. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China. Vaccine. 2013;31:3536-42. doi:10.1016/j.vaccine.2013.05.076. PMID:23791547
   PubMed Web of Science ®Google Scholar
• Cattoli G, Fusaro A, Monne I, Coven F, Joannis T, El-Hamid HSA, Hussein AA, Cornelius C, Amarin NM, Mancin M, et al. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine. 2011;29:9368-75. doi:10.1016/j.vaccine.2011.09.127.
   PubMed Web of Science ®Google Scholar
• Dinis JM, Florek NW, Fatola OO, Moncla LH, Mutschler JP, Charlier OK, Meece JK, Belongia EA, Friedrich TC. Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans. J Virol. 2016;90:3355-65. doi:10.1128/JVI.03248-15. PMID:26739054
   PubMed Web of Science ®Google Scholar
• Debbink K, McCrone JT, Petrie JG, Truscon R, Johnson E, Mantlo EK, Monto AS, Lauring AS. Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses. PLoS Pathog. 2017;13:e1006194. doi:10.1371/journal.ppat.1006194.
   PubMed Web of Science ®Google Scholar
• Cushing A, Kamali A, Winters M, Hopmans ES, Bell JM, Grimes SM, Xia LC, Zhang NR, Moss RB, Holodniy M, et al. Emergence of Hemagglutinin Mutations During the Course of Influenza Infection. Sci Rep. 2015;5:16178. doi:10.1038/srep16178. PMID:26538451
   PubMed Web of Science ®Google Scholar
• Sobel Leonard A, McClain MT, Smith GJD, Wentworth DE, Halpin RA, Lin X, Ransier A, Stockwell TB, Das SR, Gilbert AS, et al. Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification. J Virol. 2016;90:11247-58. doi:10.1128/JVI.01657-16. PMID:27707932
   PubMed Web of Science ®Google Scholar
• Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NMH, Pham QT, et al. Antibody landscapes after influenza virus infection or vaccination. Science. 2014;346:996-1000. doi:10.1126/science.1256427.
   PubMed Web of Science ®Google Scholar
• Cobey S, Hensley SE. Immune history and influenza virus susceptibility. Curr Opin Virol. 2017;22:105-11. doi:10.1016/j.coviro.2016.12.004.
   PubMed Web of Science ®Google Scholar
• Xie H, Li L, Ye Z, Li X, Plant EP, Zoueva O, Zhao Y, Jing X, Lin Z, Kawano T, et al. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera. Clin Infect Dis. 2017; 65:259-67. doi:10.1093/cid/cix269.
   Web of Science ®Google Scholar
• Xie H, Wan X-F, Ye Z, Plant EP, Zhao Y, Xu Y, Li X, Finch C, Zhao N, Kawano T, et al. H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps. Sci Rep. 2015;5:15279. doi:10.1038/srep15279. PMID:26472175
   PubMed Web of Science ®Google Scholar
• Fonville JM, Fraaij PLA, de Mutsert G, Wilks SH, van Beek R, Fouchier RAM, Rimmelzwaan GF. Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection. J Infect Dis. 2016;213:31-8. doi:10.1093/infdis/jiv367. PMID:26142433
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635-45. doi:10.1056/NEJMoa1315727. PMID:25119609
   PubMed Web of Science ®Google Scholar
• Luksza M, Lässig M. A predictive fitness model for influenza. Nature. 2014;507:57-61. doi:10.1038/nature13087. PMID:24572367
   PubMed Web of Science ®Google Scholar